Karmanos Cancer Institute's Bone Marrow or Stem Cell Program includes specialists who bring years of experience to the field of transplantation. Each patient receives personal attention from the Multidisciplinary Team, which is why our program is one of only a select group nationwide reporting some of the best survival outcomes for related and unrelated stem cell transplantation.
Patient Power Hodgkin lymphoma is a treatable cancer, and many patients diagnosed with it will be cured. Though stage does matter when it comes to prognosis, Dipenkumar Modi, M.D. , hematologist and medical oncologist, and member of the Bone Marrow and Stem Cell Transplant and Hematology Oncology Multidisciplinary Teams at Karmanos, shared some promising new therapies and immunotherapies that have helped improve patient outcomes. Read the article here .
Patient Power Nodular sclerosis Hodgkin lymphoma (NSHL) is the most common type of classical Hodgkin lymphoma (cHL), a cancer of the lymphatic system. Dipenkumar Modi, M.D. , hematologist and medical oncologist, and member of the Bone Marrow and Stem Cell Transplant and Hematology Oncology Multidisciplinary Teams at Karmanos, describes the different ways to treat NSHL and its generally favorable prognosis. Read the article here .
The Office of Faculty Affairs and Professional Development at Wayne State University’s (WSU) School of Medicine held its 2024 School of Medicine Faculty Awards and Promotion and Tenure Ceremony on Sept. 26. This is an annual recognition of faculty who have made outstanding contributions to teaching, mentoring, research, and leadership. This year, several Barbara Ann Karmanos Cancer Institute faculty, researchers and medical staff at the Karmanos Cancer Center received these awards, highlighting their si...